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The Role of Optimism/Pessimism in HRQOL in Chronic Hepatitis C Patients
Cheryl A. Moyer,1,4 Robert J. Fontana,2 Khozema Hussain,2 Anna S. F. Lok,2 and Steven Schwartz3
One hundred and twenty three outpatients with compensated chronic hepatitis C (CHC)
completed the SF-36, BSI, and questions regarding the expected impact of CHC on their
health. Respondents were categorized as optimists (N = 17, 13.8%), realists (N = 98, 79.6%),
and pessimists (N = 8, 6.5%). Pessimism was associated with lower scores on nearly all SF-36
subscales (p < .001–.03) and higher scores on 6 BSI subscales indicative of greater emotional
distress (p < .05). Pessimism was not associated with demographics, liver disease severity,
substance abuse, or comorbid medical conditions. However, pessimism was associated with the
presence of a psychiatric comorbidity and self-reported health status (p < .05). We conclude
that optimism/pessimism may be an important determinant of QOL and emotional status in
CHC patients and that additional studies of cognitive predispositions and coping skills in CHC
patients are warranted.
KEY WORDS: optimism; pessimism; emotional status; quality of life; hepatitis C; cognitive
predispositions.
INTRODUCTION
Approximately 4 million Americans are chron-
ically infected with hepatitis C, representing 1–2% of
the U.S. population (Alter et al., 1999). Although most
chronic hepatitis C (CHC) patients are largely asymp-
tomatic in the early stages of their illness, several stud-
ies have reported reductions in health-related quality
of life (HRQOL) when compared to healthy individu-
als. (Bayliss et al., 1998; Bonkovsky et al., 1999; Davis
et al., 1994; Foster, Goldin, & Thomas, 1998; Hunt
et al., 1997; Ware, Bayliss, Mannocchia, & Davis,
1999). These reductions persist, even when controlling
for such factors as liver disease severity (Fontana et
al., 2001; Hussain et al., 2001), demographics (Fontana
et al., 2001; Hussain et al., 2001), and the presence of
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medical and psychiatric comorbidities (Fontana et al.,
2002; Hussain et al., 2001; Moyer et al., 2000). In other
words, even patients with asymptomatic hepatitis C
and no other medical or psychiatric illnesses report
lower HRQOL along most measurable dimensions
than similar healthy controls. The reason for impaired
HRQOL in CHC patients is not clear. HRQOL is an
entirely subjective concept, derived from patients’
self-assessments of their overall and domain-specific
well-being. This subjectivity has raised questions
about factors that may influence quality of life
assessment, such as cognitive predispositions like
optimism or pessimism. The primary aim of our study
was to determine if there is a significant relationship
between optimism/pessimism and HRQOL and emo-
tional status in a group of CHC patients. The results
of our study in 123 consecutive CHC outpatients not
receiving antiviral therapy are presented.
METHODS
Study Population
Consecutive eligible CHC patients attending the
Hepatology Clinic at the University of Michigan
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Hospital during a 7-month period between October
1999 and May 2000 were invited to participate in the
study. The study was approved by the institutional
review board at the University of Michigan Hospi-
tal and written informed consent was obtained from
each patient. The inclusion criteria were detectable
hepatitis C antibody and/or hepatitis C virus RNA
(HCV RNA), with or without elevation in serum ALT
level. Men and women of all races between the age
of 15 and 70 years were included. Patients who were
receiving or had received treatment with interferon
alone or in combination with ribavirin during the past
3 months and sustained responders to previous ther-
apy were excluded. Patients with decompensated liver
disease, coinfection with hepatitis B or human im-
munodeficiency virus, other causes of liver disease,
malignancies in the past 1 year, life-threatening medi-
cal problems, or marrow/organ transplantations were
also excluded. Potentially eligible participants were
invited to complete a confidential survey prior to or
after their clinic visit (Fontana et al., 2002; Hussain
et al., 2001), and medical records and laboratory test
results were reviewed.
Data Collection
A 67-item self-administered survey with the
SF-36 embedded within it and the 53-item Brief
Symptom Index (BSI) were used to collect data on
HRQOL, demographics, risk factors for HCV in-
fection, patients’ knowledge about transmission and
prognosis of CHC, alcohol and drug use history, and
emotional distress as previously described (Fontana
et al., 2002; Hussain et al., 2001). Patients who re-
ported a history of intravenous drug use or a history
of regular alcohol consumption were asked if they
ever considered themselves to be dependent on drugs
or alcohol. History of current comorbid medical or
psychiatric illness was obtained by a clinical study
coordinator and corroborated with physicians’ notes
and medication lists. Reports of liver biopsies per-
formed within the last 2 years were reviewed for pres-
ence or absence of cirrhosis. Serum ALT levels within
3 months of the study visit were recorded.
Defining Optimists and Pessimists
Our instrument included a question about pa-
tients’ expectations with regard to the impact they
thought CHC would have on their lives. The options
ranged from “I will continue to stay healthy” to “I
will become sick very rapidly and I might die from
liver disease in a few years.” We recoded patients’
responses based on the clinical likelihood of each sce-
nario. Those who said they would continue to stay
healthy were recoded as optimists, those who said
they would slowly become sick and may or may not
eventually die from liver disease were coded as re-
alists. Those who said they would become sick very
rapidly and might die from liver disease in a few years
were coded as pessimists. Those who said they did not
know the impact of hepatitis C were treated as “un-
knowns,” and analysis was completed both including
and excluding the separate category of “unknowns.”
The results were similar regardless of the inclusion
of the “unknowns,” and no significant differences in
patient characteristics were found when comparing
“unknowns” to optimists, pessimists, or realists. As
the purpose of this paper is to compare optimists and
pessimists, the “unknowns” were omitted from this
analysis.
Assessment of HRQOL
The SF-36 is a self-administered, generic
HRQOL instrument that assesses function and well-
being via multi-item scales measuring the follow-
ing eight domains (Ware et al., 1995; Ware and
Sherbourne, 1992; Ware, Snow, Kosinkio, & Crandek,
1993): physical functioning (PF), role physical (RP),
role emotional (RE), vitality (VT), mental health
(MH), social functioning (SF), general health (GH),
and bodily pain (BP). Physical and mental health sum-
mary scores (PCS, MCS) were also calculated. The
SF-36 subscale scores range from 0 (lowest) to 100
(highest), and summary scores center around a pop-
ulation mean of 50 with a standard deviation of 10
(Ware et al., 1993, 1995; Ware and Sherbourne, 1992).
Assessment of Emotional Functioning
Emotional functioning was assessed using the
BSI (National Computer Systems Inc., Minneapolis,
MN). The BSI is a 53-item self-administered ques-
tionnaire (Derogatis and Cleary, 1977; Derogatis and
Melisaratos, 1983) that assesses nine domains: som-
atization (SOMA), obsessive–compulsive (OC), in-
terpersonal sensitivity (IPS), depression (DEP), anx-
iety (ANX), hostility (HOS), phobic anxiety (PHOB),
paranoid ideation (PAR), and psychoticism (PSY).
The BSI subscale scores are created by aggregating
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response to sets of questions and converting them to
area T-scores with a mean value of 50 and a stan-
dard deviation of 10. The area T-scores are deter-
mined by comparing subject responses to those of
gender-matched, nonpsychiatric population controls
(Derogatis, 1993). The BSI also generates a summary
measure, the Global Severity Index (GSI).
Data Analyses
Descriptive statistics were calculated and re-
ported as mean ± standard deviation unless indi-
cated otherwise. SF-36 scores were calculated using
SAS software (SAS Inc., Cary, NC). Statistical anal-
ysis was performed using SPSS for Windows 1997
(SPSS Inc., Chicago, IL). Normative population data
for SF-36 scores were obtained through the Medi-
cal Outcomes Trust (Ware et al., 1993). Comparisons
of U.S. population data with our sample were con-
ducted using t tests and ANOVA. Univariate analysis
of associations between clinical variables of interest
and optimism/pessimism were determined using cor-
relations, Student’s t test, ANOVA, chi-square, and
Kruskal–Wallis tests. Tukey’s test (α = .05) for multi-
ple comparisons was used to determine which groups
Table I. Patient Characteristics by Optimism/Pessimism
All patients Optimists Realists Pessimists P value
(N = 123) (N = 17, 13.8%) (N = 98, 79.6%) (N = 8, 6.5%) (comparing opt/real/pess)
Age 46.9± 7.9 44.2± 8.6 47.3± 7.7 47.0± 8.1 NS
(mean ± SD) (R:20–69)
Gender 59.3 70.5 59.2 37.5 NS
(% male)
Race (%) White: 84.6 58.8 88.7 87.5
Black: 5.7 23.5 2.0 12.5 P = .003
Other: 9.7 17.6 9.2 0
Marital status 69.9 76.5 69.4 62.5 NS
(% married)
Education (%) Some HS: 6.5 5.8 7.1 0
HS grad: 57.7 47.1 57.1 87.5 NS
Col grad+: 35.8 47.1 35.7 12.5
Medical 64.9 57.1 66.25 66.6 NS
comorbidity (%)
Psychiatric 21.1 17.6 18.4 62.5 P = .013
comorbidity (%)
Self-assessed 3.3± 1.03 2.47± 0.94 3.4± .97 4.0± 0.75 P < .001
health status
(1 = excellent to
5 = poor
Cirrhosis (%) 27.6 11.7 24.5 12.5 NS




contributed to the significant overall differences for
continuous variables found significant via ANOVA.
Pairwise comparisons were performed using Mann–




Two hundred and twenty patients completed the
survey instruments, with 214 responding to the ques-
tion about the impact they thought CHC would have
on their future health. Of those 214 respondents, 91
(42.5%) reported not knowing the potential impact
of CHC. As mentioned, there were no significant dif-
ferences between the 91 “don’t knows” and the re-
maining 123 patients, and the “don’t knows” were re-
moved from subsequent analyses. The remaining 123
were categorized as optimists (N = 17, 13.8%), real-
ists (N = 98, 79.6%), and pessimists (N = 8, 6.5%).
African Americans in our sample were significantly
more likely to be optimistic than their Caucasian
counterparts [p = .003, overall chi-square (Table I)].
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Pairwise comparison of race for optimists vs. realists
indicated a significant difference at p = .003. There
were no significant differences between optimists and
pessimists or between realists and pessimists with re-
gard to race.
Optimism/Pessimism and HRQOL
Figure 1(a) illustrates the difference between
SF-36 scores for the general U.S. population (Ware
et al., 1993) and our 123 patients. On all subscales
and summary scores, our CHC patients scored sig-
nificantly lower than the general U.S. population
(Fig. 1(a)). Figure 1(b) illustrates SF-36 scores for
optimists, realists, and pessimists with CHC com-
pared to the general U.S. population (Ware et al.,
1993). While significant differences exist among
groups on all subscales except bodily pain, opti-
mists’ scores were similar to those of the general
U.S. population, realists’ scores were lower, and
pessimists scores were consistently the lowest. Us-
ing Tukey’s test for multiple comparisons, optimists
scored significantly higher (p < .05) than pessimists
on the general health, mental health, and vitality sub-
scales, as well as on the physical health and mental
health summary scores. Optimists scored significantly
higher than realists on the general health subscale
(p < .05), and realists scored significantly higher
than pessimists on the mental health and vitality
subscales.
Optimism/Pessimism and Emotional Status
Figure 2 illustrates BSI scores for optimists,
realists, and pessimists with CHC compared to the
general U.S. population norm. With higher BSI scores
indicative of greater emotional distress, there were
significant differences among optimists, pessimists,
and realists on BSI subscale scores for SOMA, OC,
IPS, DEP, and PHOB, as well as on the GSI sum-
mary measure, indicative of global emotional distress.
Tukey’s tests for multiple comparisons indicated that,
compared to optimists, pessimists had significantly el-
evated BSI scores for SOMA, IPS, DEP, and PHOB,
as well as on the GSI at p<.05. Pessimists also had
significantly elevated BSI scores when compared to
realists on the IPS, DEP, and PHOB subscales, as well
as on the GSI (p < .05). Optimists and realists were
not significantly different on any BSI subscale or the
GSI.
Correlates of Optimism/Pessimism
The presence and number of medical comor-
bidities was not associated with optimism/pessimism
(Table I). However, having a history of psychi-
atric illness (defined as ever having sought treat-
ment or taken medication for an emotional or psy-
chiatric problem) was associated with an increased
likelihood of being pessimistic [p = .013, overall
chi-square; pessimist vs. realist, p = .004; pessimist
vs. optimist, p = .03; realist vs. optimist, p = .302
(NS)]. In addition, a higher self-reported health sta-
tus was associated with optimism [p < .001, over-
all ANOVA; optimist vs. pessimist, p = .001; opti-
mist vs. realist, p = .001; realist vs. pessimist, p = .23
(NS)].
Other baseline demographic and clinical
variables were tested for association with opti-
mism/pessimism. Nonresponse to previous antiviral
therapy, the presence of cirrhosis, and elevated
serum ALT were not associated with optimism or
pessimism. In addition, substance abuse history
including intravenous drug use, self-defined drug de-
pendence, and history of alcohol abuse did not show
significant associations with optimism or pessimism
(data not shown).
DISCUSSION
Our results indicate that pessimists have lower
SF-36 scores than realists and optimists, with optimists
closely matching the general U.S. population’s qual-
ity of life scores. In addition, pessimists report poorer
health status and greater emotional distress than both
optimists and realists (Fig. 2, Table I). Our findings are
consistent with other previous studies demonstrating
significantly lower HRQOL scores in CHC patients
compared to the general U.S. population (Bayliss
et al., 1998; Bonkovsky et al., 1999; Davis et al., 1994;
Fontana et al., 2001, 2002; Foster et al., 1998; Hunt
et al., 1997; Hussain et al., 2001; Moyer et al., 2000;
Ware et al., 1999). The reasons why CHC patients
report a consistently lower HRQOL compared to
healthy matched controls remain unclear. Previous
research has suggested that there may be a perceived
stigma attached to CHC, such that patients who have
had the illness longer may be more negatively emo-
tionally impacted by the diagnosis (Kraus et al., 2000).
It is possible that patients with CHC develop inef-
fective coping skills as they learn more about their
condition, which has an uncertain and variable natural
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history (Glacken, Kernohan, & Coates, 2001; Kraus,
Schäfer, Csef, Scheurlen, & Faller, 2000). Our data
suggest that optimism/pessimism as well as coping
skills may be an important determinant of HRQOL
in CHC patients.
Previous research suggests that cognitive predis-
positions such as optimism/pessimism may play a sig-
nificant role in how a person copes with chronic illness
and assesses his symptoms (Affleck, Tennen, & Apter,
2001). In addition, optimism/pessimism may influ-
ence health outcomes (Peterson & Seligman, 1984;
Peterson, Seligmen, Yurko, Martin, & Friedman,
1998; Peterson, Vaillant, & Seligman, 1988). For ex-
ample, Affleck and colleagues found that the most
optimistic asthma patients were least likely to take
extra medication for worsening symptoms, whereas
the most pessimistic asthma patients were more likely
to vent distressing emotions (Affleck et al., 2001).
In the Terman Life-Cycle Study, results indicate
that pessimism—as measured via questionnaires com-
pleted in the 1930s and 1940s—was a strong predictor
of early mortality as of 1991, especially among males,
and especially for accidental or violent deaths (Peter-
son et al., 1998). Similarly, Peterson and colleagues
found that pessimism among Harvard graduates in
the 1940s predicted poor health at ages 45 through
60, even when physical and mental health at age 25
were controlled (Peterson et al., 1988).
The results of studies such as these suggest that
pessimism can influence a person’s coping style, over-
all emotional well-being, and health status. Conse-
quently, it is not unreasonable to suggest that pes-
simism or perception of a disease’s impact on future
health may also affect perceptions of HRQOL. Not
surprisingly, we found that pessimism among CHC pa-
tients was associated with a history of psychiatric ill-
ness and a lower self-reported health status (Table I).
However, patients with a history of substance abuse
or more severe liver disease were not more likely to be
pessimistic. Pessimistic CHC patients in our study did
report significantly higher BSI subscale and summary
scores indicative of greater emotional distress.
There are several limitations to this study worth
discussing. First, the overall sample size is relatively
small, and the distribution of optimists, realists, and
pessimists was skewed such that there was a small
number of optimists and pessimists. We utilized non-
parametric statistics to account for the skewed dis-
tribution, but it is possible that a more equally split
sample might yield different results. Second, our mea-
sure of optimism/pessimism was not a validated in-
strument. Our single-item assessment of patients’ per-
ception of the potential impact of CHC on their lives
may not yield the same results as a multi-item instru-
ment that has been subjected to rigorous psychome-
tric testing. Finally, our sample consisted of patients
visiting a tertiary care center for treatment for their
CHC, which may lead to a referral bias compared to
CHC patients in the general U.S. population.
Although our pilot study suggests that opti-
mism/pessimism may play an important role in QOL,
more research is needed. For example (1) Does opti-
mism alone compensate for the degradations in QOL
caused by CHC, or is it the absence of pessimism?
(2) How does coping style interact with optimism
and pessimism in this population, and how does that
consequently affect QOL? (3) How do optimism and
pessimism impact upon CHC patients’ perception of
symptoms? (4) Do optimism and pessimism affect
both emotional and physical dimensions of QOL?
and (5) If optimism and pessimism genuinely affect
the physical dimensions of QOL, are there explana-
tory mechanisms? (e.g. altering specific health risk
behaviors like drug use or more general health be-
haviors like exercise, or is there some as yet unidenti-
fied psychoneuroimmunological process underway?)
It also worth exploring whether optimism/pessimism
has psychotherapeutic treatment implications. Can
we turn pessimists into optimists, and if so, what ef-
fect might that have on QOL, emotional distress, and
health outcomes? Future population-based studies
using larger sample sizes may confirm or alter our
preliminary findings. Nonetheless, our data suggest
that optimism/pessimism may be an important factor
worth considering in future investigations of HRQOL
and emotional status in CHC patients.
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